Pular para o conteúdo
Merck
  • SIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidation.

SIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidation.

Molecular and cellular biology (2013-09-18)
Gaëlle Laurent, Vincent C J de Boer, Lydia W S Finley, Meredith Sweeney, Hong Lu, Thaddeus T Schug, Yana Cen, Seung Min Jeong, Xiaoling Li, Anthony A Sauve, Marcia C Haigis
RESUMO

Sirtuins are a family of protein deacetylases, deacylases, and ADP-ribosyltransferases that regulate life span, control the onset of numerous age-associated diseases, and mediate metabolic homeostasis. We have uncovered a novel role for the mitochondrial sirtuin SIRT4 in the regulation of hepatic lipid metabolism during changes in nutrient availability. We show that SIRT4 levels decrease in the liver during fasting and that SIRT4 null mice display increased expression of hepatic peroxisome proliferator-activated receptor α (PPARα) target genes associated with fatty acid catabolism. Accordingly, primary hepatocytes from SIRT4 knockout (KO) mice exhibit higher rates of fatty acid oxidation than wild-type hepatocytes, and SIRT4 overexpression decreases fatty acid oxidation rates. The enhanced fatty acid oxidation observed in SIRT4 KO hepatocytes requires functional SIRT1, demonstrating a clear cross talk between mitochondrial and nuclear sirtuins. Thus, SIRT4 is a new component of mitochondrial signaling in the liver and functions as an important regulator of lipid metabolism.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Anti-actina, affinity isolated antibody, buffered aqueous solution
Millipore
Gel de afinidade M2 EZview Vermelho ANTI-FLAG®, clone M2
Sigma-Aldrich
β-Dinucleotídeo de nicotinamida adenina, ≥95% (HPLC)
Sigma-Aldrich
β-Dinucleotídeo de nicotinamida adenina, Grade AA-1
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide, pkg of 10 mg (per vial)
Sigma-Aldrich
β-Dinucleotídeo de nicotinamida adenina, suitable for cell culture, ≥96.5% (HPLC), ≥96.5% (spectrophotometric assay), from yeast
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide, pkg of 50 mg (per vial)
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide, pkg of 20 mg (per vial)
Sigma-Aldrich
Anti-Sirt1(Sir2) Antibody, Upstate®, from rabbit
Sigma-Aldrich
β-Dinucleotídeo de nicotinamida adenina, ≥96.5% (HPLC), ≥96.5% (spectrophotometric assay), from yeast
Sigma-Aldrich
β-Dinucleotídeo de nicotinamida adenina, ≥99%
Sigma-Aldrich
β-Dinucleotídeo de nicotinamida adenina, ≥98%, BioUltra, from yeast
Sigma-Aldrich
β-Dinucleotídeo de nicotinamida adenina, purified by column chromatography, ≥99%